Clinical Trial Update: A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 [NA]

View source ↗

Summary

A completed prospective clinical evaluation of the Total Vascular Access (TVA) FLEX-1 Device (protocol FLEX-1-001) sponsored by C. R. Bard is reported. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Total Vascular Access (TVA) FLEX-1 Device

Snippet

Sponsor: C. R. Bard | Conditions: Chronic Kidney Disease (CKD) | NA | Status: COMPLETED